Jazieh Abdul Rahman, Bounedjar Adda, Al Dayel Foad, Fahem Shamayel, Tfayli Arafat, Rasul Kakil, Jaafar Hassan, Jaloudi Mohammad, Al Fayea Turki, Almaghrabi Hatim Q, Bamefleh Hanaa, AlKattan Khaled, Larbaoui Blaha, Filalli Taha, Al Mistiri Mufid, Alhusaini Hamed
King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
J Thorac Dis. 2019 Dec;11(12):5162-5168. doi: 10.21037/jtd.2019.12.03.
Accurate pathological diagnosis is the first critical step in the management of lung cancer. This step is important to determine the histological subtype of the cancer and to identify any actionable targets. Our study aimed at evaluating the patterns of procedures used to obtain pathological diagnosis of lung cancer in the Middle East and North Africa (MENA) Region.
Data of consecutive patients with the diagnosis of non-small cell lung cancer (NSCLC) were collected from participating centers from different countries in the MENA Region. Methods of obtaining tissue diagnosis and workup were analyzed to determine the practice patterns of obtaining tissue diagnosis of lung cancer.
A total of 566 patients were recruited from 10 centers in 5 countries including Saudi Arabia, United Arab Emirates (UAE), Qatar, Lebanon and Algeria. Majority of patients were males (78.1%) with a median age of 61 years (range, 22-89 years). Obtaining tissue diagnosis was successful in the first attempt in 72.3% of patients, while 16.4% and 6.3% of patients required 2 and 3 attempt, respectively. The success in first attempt was as follows: image guided biopsy (91%), surgical biopsy (88%), endobronchial biopsy (79%) and cytology (30%). The success in the second attempt was as follows; surgical biopsy (100%), image guided biopsy (95%), endobronchial biopsy (65%), cytology (25%).
More than quarter of the patients required repeated biopsy in the MENA Region. Image guided biopsy has the highest initial yield. Implementing clear process and multidisciplinary guidelines about the selection of diagnostic procedures is needed.
准确的病理诊断是肺癌治疗的首要关键步骤。这一步骤对于确定癌症的组织学亚型以及识别任何可采取行动的靶点至关重要。我们的研究旨在评估中东和北非(MENA)地区用于获取肺癌病理诊断的程序模式。
从MENA地区不同国家的参与中心收集连续诊断为非小细胞肺癌(NSCLC)患者的数据。分析获取组织诊断和检查的方法,以确定获取肺癌组织诊断的实践模式。
共从包括沙特阿拉伯、阿拉伯联合酋长国(阿联酋)、卡塔尔、黎巴嫩和阿尔及利亚在内的5个国家的10个中心招募了566例患者。大多数患者为男性(78.1%),中位年龄为61岁(范围22 - 89岁)。72.3%的患者首次尝试获取组织诊断成功,而分别有16.4%和6.3%的患者需要进行2次和3次尝试。首次尝试的成功率如下:影像引导活检(91%)、手术活检(88%)、支气管内活检(79%)和细胞学检查(30%)。第二次尝试的成功率如下:手术活检(100%)、影像引导活检(95%)、支气管内活检(65%)、细胞学检查(25%)。
在MENA地区,超过四分之一的患者需要重复活检。影像引导活检的初始成功率最高。需要实施关于诊断程序选择的明确流程和多学科指南。